Clinical Trials Directory

Trials / Conditions / Ovarian Undifferentiated Adenocarcinoma

Ovarian Undifferentiated Adenocarcinoma

8 registered clinical trials studyying Ovarian Undifferentiated Adenocarcinoma.

StatusTrialSponsorPhase
CompletedMetformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritone
NCT02122185
University of ChicagoPhase 2
CompletedBelinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallop
NCT00993616
National Cancer Institute (NCI)Phase 2
CompletedSargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ova
NCT00466960
University of WashingtonPhase 2
CompletedDenileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carc
NCT00357448
University of WashingtonPhase 1
CompletedPaclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulkin
NCT00079430
National Cancer Institute (NCI)Phase 1
CompletedCarboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in T
NCT00085358
National Cancer Institute (NCI)Phase 1
CompletedErlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma
NCT00059787
National Cancer Institute (NCI)Phase 2
CompletedPaclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stag
NCT00002913
National Cancer Institute (NCI)Phase 1